KIM, KYUNG JIN,PARK, HANGIL,DING, YI,ZHANG, APRIL,WANG, LIHONG,VASQUEZ, MAXIMILIANO
申请号：
CA2998343
公开号：
CA2998343A1
申请日:
2016.09.13
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention is directed toward neutralizing monoclonal antibodies to Vascular Endothelial Growth Factor (VEGF) and angiopoietin 2 (Ang-2), pharmaceutical compositions comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
